BioCentury
ARTICLE | Company News

Altus endocrine news

September 21, 2009 7:00 AM UTC

Altus said it will wind down its business operations and terminate substantially all of its employees. Altus also suspended its pediatric Phase II trial of ALTU-238 for growth hormone deficiency (GHD...